| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,633,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,434,166 |
Avg
Vol: |
650,831 |
| 52
Week Range: |
$21.74 - $21.74 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cable Stuart M |
10% Owner |
– – • |
2014-06-02 |
4 |
AS |
$16.40 |
$492,000 |
I/I |
(30,000) |
4,233,289 |
|
- |
|
| Henderson Lori M |
SVP, Secretary & Gen. Counsel |
• – – |
2014-06-02 |
4 |
AS |
$16.32 |
$40,800 |
D/D |
(2,500) |
51,497 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(453) |
31,730 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,250) |
32,183 |
|
- |
|
| Henderson Lori M |
SVP, Secretary & Gen. Counsel |
• – – |
2014-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(476) |
49,563 |
|
- |
|
| Henderson Lori M |
SVP, Secretary & Gen. Counsel |
• – – |
2014-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,458) |
50,039 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, Board of Directors |
– • – |
2014-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,667) |
2,841,879 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-05-16 |
4 |
S |
$15.45 |
$19,313 |
D/D |
(1,250) |
33,433 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-05-16 |
4 |
OE |
$2.93 |
$3,663 |
D/D |
1,250 |
34,683 |
|
- |
|
| Svokos George |
SVP Sales & GM of API |
• – – |
2014-05-15 |
4 |
B |
$15.60 |
$156,000 |
D/D |
10,000 |
54,584 |
2.74 |
- |
|
| Marth William S |
President and CEO |
• • – |
2014-05-12 |
4 |
B |
$15.40 |
$462,000 |
D/D |
30,000 |
313,699 |
2.81 |
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-05-12 |
4 |
S |
$15.27 |
$38,175 |
D/D |
(2,500) |
33,433 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-05-12 |
4 |
OE |
$2.93 |
$7,325 |
D/D |
2,500 |
35,933 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-05-09 |
4 |
S |
$14.80 |
$50,276 |
D/D |
(3,397) |
33,433 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2014-05-09 |
4 |
OE |
$2.93 |
$7,325 |
D/D |
2,500 |
35,933 |
|
- |
|
| Cable Stuart M |
10% Owner |
– – • |
2014-05-01 |
4 |
AS |
$15.98 |
$479,400 |
I/I |
(30,000) |
4,263,289 |
|
- |
|
| Henderson Lori M |
VP, Secretary & Gen. Counsel |
• – – |
2014-05-01 |
4 |
AS |
$15.73 |
$39,325 |
D/D |
(2,500) |
53,997 |
|
- |
|
| Cable Stuart M |
10% Owner |
– – • |
2014-04-01 |
4 |
AS |
$18.52 |
$555,600 |
I/I |
(30,000) |
4,293,289 |
|
- |
|
| Henderson Lori M |
VP, Secretary & Gen. Counsel |
• – – |
2014-04-01 |
4 |
AS |
$18.74 |
$46,850 |
D/D |
(2,500) |
56,497 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-03-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(254) |
34,330 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(254) |
34,584 |
|
- |
|
| Cable Stuart M |
10% Owner |
– – • |
2014-03-03 |
4 |
AS |
$15.42 |
$462,600 |
I/I |
(30,000) |
4,323,289 |
|
- |
|
| Oconnor Kevin |
Director |
– • – |
2014-02-27 |
4 |
OE |
$12.85 |
$64,250 |
D/D |
5,000 |
40,210 |
|
- |
|
| Roth Arthur J |
Director |
– • – |
2014-02-27 |
4 |
S |
$15.95 |
$79,750 |
D/D |
(5,000) |
36,856 |
|
- |
|
| Roth Arthur J |
Director |
– • – |
2014-02-27 |
4 |
OE |
$12.85 |
$64,250 |
D/D |
5,000 |
41,856 |
|
- |
|
620 Records found
|
|
Page 12 of 25 |
|
|
